Most recently, it has been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to the big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger https://roberto753ikk3.blogozz.com/profile